Search the Archive

Senate / Drug Patent / Claritin #183674

ABC Evening News for Wednesday, Nov 10, 1999
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Peter Jennings) Report introduced.

(Washington: Jackie Judd) Senate Judiciary Committee hearings to consider a bill allowing the Schering-Plough pharmaceutical company to continue making profits from the allergy drug Claritin without competition featured; details given of the lobbying by Schering-Plough. [Senator Patrick LEAHY - likens Claritin to "the cookie jar."] [Public Citizen's Congress Watch Frank CLEMENTE - says the company was told to get liberal Democrats on board.] Schering-Plough contributions to Senators Robert Torricelli and Orrin Hatch cited. [Presidential candidate HATCH - says it was within the rules.]

Jennings, Peter;
Judd, Jackie

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.